Desmoid Tumor Completed Phase 1 / 2 Trials for Nivolumab (DB09035)

Also known as: Desmoid-Type Fibromatosis / Desmoid Type-fibromatosis / Aggressive Fibromatosis / Desmoid tumour / Fibromatosis, Aggressive / Desmoid Tumors / Fibromatosis Desmoid / Desmoid Fibromatosis / Aggressive fibromatosis (disorder) / Aggressive fibromatosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0028471 (Desmoid Tumor)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03190174Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersTreatment